S&P 500   3,103.54 (-0.16%)
DOW   27,766.29 (-0.20%)
QQQ   201.70 (-0.22%)
MSFT   149.48 (-0.09%)
GOOGL   1,300.14 (-0.13%)
AMZN   1,734.71 (-0.62%)
CGC   20.29 (+15.02%)
NVDA   210.18 (-0.47%)
MU   45.55 (-0.04%)
BABA   184.86 (+1.38%)
GE   11.53 (+1.23%)
T   37.60 (+1.13%)
AMD   39.52 (-3.56%)
ACB   3.12 (+18.18%)
F   8.71 (-0.23%)
PRI   130.45 (-0.81%)
NFLX   311.69 (+2.14%)
BAC   32.84 (+0.46%)
GILD   65.73 (+1.31%)
DIS   146.90 (-0.02%)
S&P 500   3,103.54 (-0.16%)
DOW   27,766.29 (-0.20%)
QQQ   201.70 (-0.22%)
MSFT   149.48 (-0.09%)
GOOGL   1,300.14 (-0.13%)
AMZN   1,734.71 (-0.62%)
CGC   20.29 (+15.02%)
NVDA   210.18 (-0.47%)
MU   45.55 (-0.04%)
BABA   184.86 (+1.38%)
GE   11.53 (+1.23%)
T   37.60 (+1.13%)
AMD   39.52 (-3.56%)
ACB   3.12 (+18.18%)
F   8.71 (-0.23%)
PRI   130.45 (-0.81%)
NFLX   311.69 (+2.14%)
BAC   32.84 (+0.46%)
GILD   65.73 (+1.31%)
DIS   146.90 (-0.02%)
S&P 500   3,103.54 (-0.16%)
DOW   27,766.29 (-0.20%)
QQQ   201.70 (-0.22%)
MSFT   149.48 (-0.09%)
GOOGL   1,300.14 (-0.13%)
AMZN   1,734.71 (-0.62%)
CGC   20.29 (+15.02%)
NVDA   210.18 (-0.47%)
MU   45.55 (-0.04%)
BABA   184.86 (+1.38%)
GE   11.53 (+1.23%)
T   37.60 (+1.13%)
AMD   39.52 (-3.56%)
ACB   3.12 (+18.18%)
F   8.71 (-0.23%)
PRI   130.45 (-0.81%)
NFLX   311.69 (+2.14%)
BAC   32.84 (+0.46%)
GILD   65.73 (+1.31%)
DIS   146.90 (-0.02%)
S&P 500   3,103.54 (-0.16%)
DOW   27,766.29 (-0.20%)
QQQ   201.70 (-0.22%)
MSFT   149.48 (-0.09%)
GOOGL   1,300.14 (-0.13%)
AMZN   1,734.71 (-0.62%)
CGC   20.29 (+15.02%)
NVDA   210.18 (-0.47%)
MU   45.55 (-0.04%)
BABA   184.86 (+1.38%)
GE   11.53 (+1.23%)
T   37.60 (+1.13%)
AMD   39.52 (-3.56%)
ACB   3.12 (+18.18%)
F   8.71 (-0.23%)
PRI   130.45 (-0.81%)
NFLX   311.69 (+2.14%)
BAC   32.84 (+0.46%)
GILD   65.73 (+1.31%)
DIS   146.90 (-0.02%)
Log in

Neovasc Stock Price, Forecast & Analysis (NASDAQ:NVCN)

$2.86
-0.03 (-1.04 %)
(As of 11/21/2019 04:00 PM ET)
Today's Range
$2.81
Now: $2.86
$2.89
50-Day Range
$2.88
MA: $3.49
$3.96
52-Week Range
$2.34
Now: $2.86
$12.30
Volume28,200 shs
Average Volume180,413 shs
Market Capitalization$21.40 million
P/E RatioN/A
Dividend YieldN/A
Beta1.55
Neovasc Inc, a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NVCN
CUSIPN/A
Phone604-248-4138

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.75 million
Book Value($3.45) per share

Profitability

Net Income$-108,040,000.00
Net Margins-544.24%

Miscellaneous

Employees98
Market Cap$21.40 million
Next Earnings Date3/19/2020 (Estimated)
OptionableNot Optionable

Receive NVCN News and Ratings via Email

Sign-up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter.


Neovasc (NASDAQ:NVCN) Frequently Asked Questions

What is Neovasc's stock symbol?

Neovasc trades on the NASDAQ under the ticker symbol "NVCN."

When did Neovasc's stock split? How did Neovasc's stock split work?

Neovasc shares reverse split on Friday, September 21st 2018. The 1-100 reverse split was announced on Tuesday, September 11th 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 20th 2018. An investor that had 100 shares of Neovasc stock prior to the reverse split would have 1 shares after the split.

How were Neovasc's earnings last quarter?

Neovasc Inc (NASDAQ:NVCN) released its earnings results on Tuesday, March, 29th. The medical equipment provider reported ($1,100.00) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($1,500.00) by $400.00. The medical equipment provider had revenue of $2.24 million for the quarter, compared to analyst estimates of $3.26 million. View Neovasc's Earnings History.

When is Neovasc's next earnings date?

Neovasc is scheduled to release their next quarterly earnings announcement on Thursday, March 19th 2020. View Earnings Estimates for Neovasc.

What price target have analysts set for NVCN?

1 equities research analysts have issued 1-year price objectives for Neovasc's stock. Their forecasts range from $9.00 to $9.00. On average, they expect Neovasc's stock price to reach $9.00 in the next year. This suggests a possible upside of 214.7% from the stock's current price. View Analyst Price Targets for Neovasc.

What is the consensus analysts' recommendation for Neovasc?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Neovasc.

Has Neovasc been receiving favorable news coverage?

News headlines about NVCN stock have trended positive this week, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Neovasc earned a daily sentiment score of 3.0 on InfoTrie's scale. They also assigned news articles about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Neovasc.

Are investors shorting Neovasc?

Neovasc saw a drop in short interest during the month of October. As of October 31st, there was short interest totalling 138,900 shares, a drop of 9.5% from the September 30th total of 153,400 shares. Based on an average daily trading volume, of 61,200 shares, the short-interest ratio is currently 2.3 days. Currently, 2.0% of the shares of the stock are sold short. View Neovasc's Current Options Chain.

Who are some of Neovasc's key competitors?

What other stocks do shareholders of Neovasc own?

Who are Neovasc's key executives?

Neovasc's management team includes the folowing people:
  • Mr. Fredericus A. Colen, Pres & CEO (Age 66)
  • Mr. Christopher Clark B.A., C.A., BA (Honours), PgD, CA, CFO & Corp. Sec. (Age 47)

How do I buy shares of Neovasc?

Shares of NVCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Neovasc's stock price today?

One share of NVCN stock can currently be purchased for approximately $2.86.

How big of a company is Neovasc?

Neovasc has a market capitalization of $21.40 million and generates $1.75 million in revenue each year. The medical equipment provider earns $-108,040,000.00 in net income (profit) each year or ($27.30) on an earnings per share basis. Neovasc employs 98 workers across the globe.View Additional Information About Neovasc.

What is Neovasc's official website?

The official website for Neovasc is http://www.neovasc.com/.

How can I contact Neovasc?

Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, Richmond A1, V6V2J7. The medical equipment provider can be reached via phone at 604-248-4138 or via email at [email protected]


MarketBeat Community Rating for Neovasc (NASDAQ NVCN)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  345 (Vote Outperform)
Underperform Votes:  266 (Vote Underperform)
Total Votes:  611
MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe NVCN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVCN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel